BRPI0513446A - métodos de liberação de droga auxiliada por dispositivo - Google Patents

métodos de liberação de droga auxiliada por dispositivo

Info

Publication number
BRPI0513446A
BRPI0513446A BRPI0513446-3A BRPI0513446A BRPI0513446A BR PI0513446 A BRPI0513446 A BR PI0513446A BR PI0513446 A BRPI0513446 A BR PI0513446A BR PI0513446 A BRPI0513446 A BR PI0513446A
Authority
BR
Brazil
Prior art keywords
agents
drug release
release methods
diagnostic
therapeutic
Prior art date
Application number
BRPI0513446-3A
Other languages
English (en)
Inventor
Stephen G Carter
Zhen Zhu
Kanu Patel
Original Assignee
Biochemics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemics Inc filed Critical Biochemics Inc
Publication of BRPI0513446A publication Critical patent/BRPI0513446A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors

Abstract

MéTODOS DE LIBERAçãO DE DROGA AUXILIADA POR DISPOSITIVO A invenção descreve a administração seqüencial e simultânea de agentes terapêuticos e diagnósticos empregando dispositivos diferentes de comum acordo com uma formulação química que incorpora ou emprega os agentes químicos vasomodulatórios como parte do veículo de liberação de droga. Os métodos incluem a adição de vários agentes vasoconstrutivos e vasodilatórios para realçar a liberação de tecido localizado e sistêmico de agentes diagnósticos e terapêuticos liberados em um corpo através de um aparato ou dispositivo.
BRPI0513446-3A 2004-09-21 2005-09-20 métodos de liberação de droga auxiliada por dispositivo BRPI0513446A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/945,593 US20060062836A1 (en) 2004-09-21 2004-09-21 Methods of device-assisted drug delivery
PCT/US2005/033617 WO2006034255A2 (en) 2004-09-21 2005-09-20 Methods of device-assisted drug delivery

Publications (1)

Publication Number Publication Date
BRPI0513446A true BRPI0513446A (pt) 2008-05-06

Family

ID=36074294

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513446-3A BRPI0513446A (pt) 2004-09-21 2005-09-20 métodos de liberação de droga auxiliada por dispositivo

Country Status (9)

Country Link
US (1) US20060062836A1 (pt)
EP (1) EP1791506A4 (pt)
JP (1) JP2008513150A (pt)
CN (1) CN101022771A (pt)
AU (1) AU2005286822B2 (pt)
BR (1) BRPI0513446A (pt)
CA (1) CA2569285C (pt)
MX (1) MX2007001222A (pt)
WO (1) WO2006034255A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9566256B2 (en) 2008-09-22 2017-02-14 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
EP2352543B1 (en) 2008-12-04 2019-04-03 BioChemics, Inc. Methods and compositions for tattoo removal
CN102612559B (zh) * 2009-08-28 2015-06-10 一般财团法人化学及血清疗法研究所 源自流感m2的修饰的肽疫苗
CN108653192A (zh) * 2018-04-23 2018-10-16 中山大学 一种用于控制释放生长激素治疗侏儒症的复合式微针贴片装置及其制作方法
CA3112808A1 (en) 2018-09-27 2020-04-02 BioPhysics Pharma, Inc. Transdermal drug delivery system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182258A (en) * 1989-03-20 1993-01-26 Orbon Corporation Systemic delivery of polypeptides through the eye
US5334138A (en) * 1990-03-15 1994-08-02 North Carolina State University Method and composition for increased skin concentration of active agents by iontophoresis
US5853751A (en) * 1993-06-23 1998-12-29 Masiz; John J. Molecular transdermal transport system
US5645854A (en) * 1993-06-23 1997-07-08 Masiz; John J. Molecular transdermal transport system
US5460821A (en) * 1993-06-23 1995-10-24 Masiz; John J. Molecular transdermal transport system
WO1999064580A1 (en) * 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US6635274B1 (en) * 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system
EP1381423A1 (en) * 2001-04-13 2004-01-21 Becton, Dickinson and Company Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
EP1589901A4 (en) * 2002-12-20 2006-08-09 Generipharm Inc INTRACUTANEOUS INJECTION
WO2004058329A2 (en) * 2002-12-20 2004-07-15 The Board Of Trustees Of The Leland Stanford Junior University Ester combination local anesthetic
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein

Also Published As

Publication number Publication date
WO2006034255A2 (en) 2006-03-30
EP1791506A4 (en) 2012-09-05
CN101022771A (zh) 2007-08-22
WO2006034255A3 (en) 2006-09-21
CA2569285A1 (en) 2006-03-30
AU2005286822A1 (en) 2006-03-30
US20060062836A1 (en) 2006-03-23
MX2007001222A (es) 2007-10-05
JP2008513150A (ja) 2008-05-01
CA2569285C (en) 2011-12-06
AU2005286822B2 (en) 2011-08-18
EP1791506A2 (en) 2007-06-06

Similar Documents

Publication Publication Date Title
IL273765A (en) Combinations and forms of administration of therapeutic agents and combined treatment
BRPI0603073A (pt) método para distribuição de fármacos para tecido sob propulsão de microjatos
WO2004087011A3 (en) Therapeutic agent delivery device with controlled therapeutic agent release rates
BRPI0519739A2 (pt) combinaÇço compreendendo um agente fornecendo um sinal, um material de implante e uma droga
DE602006017661D1 (de) Katheter mit distaler wirkstofffreisetzungseinheit
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
DE602005011653D1 (de) Medizinprodukt mit gewebeabhängiger arzneimittelelution
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
MX2015015589A (es) Composiciones y metodos para el suministro de agentes activos hidrófobos.
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
AR060306A1 (es) Terapia de combinacion de anticuerpos contra ctla4
BR0306513A (pt) tampão com medicamento
BRPI0513446A (pt) métodos de liberação de droga auxiliada por dispositivo
WO2009120484A3 (en) Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
BR112012014159A2 (pt) Combinações terapêuticas de teobromina e um anti-histamínico
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
GB0306977D0 (en) Device
BRPI0607172A2 (pt) método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos
UA105944C2 (uk) Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю
WO2005087792A3 (en) Materials and methods relating to the treatment of glioblastomas
UA105940C2 (uk) Лікарська комбінація з теоброміном та опіатом і її використання в лікуванні кашлю
ES1060042Y (es) Dispositivo de suministro de medicamentos
BRPI0515427A (pt) solução viscoelástica ou formulação em gel, e métodos de tratamento de um local do corpo com estas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 16A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.